CMR Versus CT in Coronary Artery Disease
ConditionCoronary Artery Disease
Trial statusRecruiting
Trial phaseNot listed
Trial typeObservational
Biological sexAll
Age18+
SponsorUniversity of Leicester
About this trial
CONCORD is a prospective observational study evaluating the diagnostic accuracy of cardiovascular magnetic resonance (CMR) and computed tomography with fractional flow reserve (CT-FFR) in patients with suspected coronary artery disease, using invasive fractional flow reserve (FFR) as the reference standard.
Eligibility criteria
Qualifiers
Patients aged ≥18 years
Referred for invasive coronary angiography for investigation of chest pain
Disqualifiers
Recent acute coronary syndrome (< 6 months)
Previous coronary artery bypass grafting
Severe claustrophobia
Absolute contraindications to CMR - those with MR conditional or safe devices will be included
Trial design
Treatments tested in this trial
- CMR and CTCA with CT-FFR
Treatment groups
No treatment groups listed
Sponsors and collaborators
University of Leicester
Lead sponsor
HeartFlow, Inc.
Collaborator
National Heart, Lung, and Blood Institute (NHLBI)
Collaborator
University of Oxford
Collaborator
University of Glasgow
Collaborator
Source ClinicalTrials.gov